Comparative analysis of species-specific ligand recognition in toll-like receptor 8 signaling: A hypothesis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Govindaraj, Rajiv Gandhi ^a   Manavalan, Balachandran ^a   Basith, Shaherin ^a   Choi, Sangdun ^a  

^a Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RESIQUIMOD; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 8; LIGAND;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; COMPARATIVE STUDY; DRUG RECEPTOR BINDING; LIGAND RECOGNITION; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR RECOGNITION; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN STRUCTURE; RODENT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SURFACE PROPERTY; ANIMAL; CATTLE; CHEMISTRY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOLECULAR GENETICS; MOUSE; PHYLOGENY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; RAT; SWINE;

BACTERIA (MICROORGANISMS); RODENTIA;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATTLE; HUMANS; IMMUNITY, INNATE; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RATS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SWINE; TOLL-LIKE RECEPTOR 8;

EID: 80052938022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025118     Document Type: Article

References (66)

1. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
2. West AP, Koblansky AA, Ghosh S, (2006) Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22: 409-437.
3. Basith S, Manavalan B, Lee G, Kim SG, Choi S, (2011) Toll-like receptor modulators: a patent review (2006-2010). Expert opinion on therapeutic patents 21: 927-944.
4. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
5. Kobe B, Kajava AV, (2001) The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11: 725-732.
6. Beutler BA, (2009) TLRs and innate immunity. Blood 113: 1399-1407.
7. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
8. Akira S, (2009) Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci 85: 143-156.
9. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, et al. (2005) The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 102: 9577-9582.
10. Park BS, Song DH, Kim HM, Choi BS, Lee H, et al. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195.
11. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, et al. (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130: 1071-1082.
12. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, et al. (2008) Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320: 379-381.
13. Choe J, Kelker MS, Wilson IA, (2005) Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309: 581-585.
14. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, et al. (2009) Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31: 873-884.
15. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917.
16. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, et al. (2006) The molecular structure of the TLR3 extracellular domain. J Endotoxin Res 12: 375-378.
17. Werling D, Jann OC, Offord V, Glass EJ, Coffey TJ, (2009) Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol 30: 124-130.
18. Higuchi M, Matsuo A, Shingai M, Shida K, Ishii A, et al. (2008) Combinational recognition of bacterial lipoproteins and peptidoglycan by chicken Toll-like receptor 2 subfamily. Dev Comp Immunol 32: 147-155.
19. Keestra AM, de Zoete MR, van Aubel RA, van Putten JP, (2007) The central leucine-rich repeat region of chicken TLR16 dictates unique ligand specificity and species-specific interaction with TLR2. J Immunol 178: 7110-7119.
20. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, et al. (2000) Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105: 497-504.
21. Lohmann KL, Vandenplas ML, Barton MH, Bryant CE, Moore JN, (2007) The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. J Endotoxin Res 13: 235-242.
22. Lizundia R, Sauter KS, Taylor G, Werling D, (2008) Host species-specific usage of the TLR4-LPS receptor complex. Innate Immun 14: 223-231.
23. Andersen-Nissen E, Smith KD, Bonneau R, Strong RK, Aderem A, (2007) A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med 204: 393-403.
24. Zhu J, Brownlie R, Liu Q, Babiuk LA, Potter A, et al. (2009) Characterization of bovine Toll-like receptor 8: ligand specificity, signaling essential sites and dimerization. Mol Immunol 46: 978-990.
25. Zhu J, Lai K, Brownile R, Babiuk LA, Mutwiri GK, (2008) Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod. Mol Immunol 45: 3238-3243.
26. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3: 196-200.
27. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, et al. (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3: 499.
28. Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, et al. (2003) The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 33: 2987-2997.
29. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
30. Barton GM, (2007) Viral recognition by Toll-like receptors. Semin Immunol 19: 33-40.
31. Di Matteo A, Federici L, Mattei B, Salvi G, Johnson KA, et al. (2003) The crystal structure of polygalacturonase-inhibiting protein (PGIP), a leucine-rich repeat protein involved in plant defense. Proc Natl Acad Sci U S A 100: 10124-10128.
32. Gong J, Wei T, Zhang N, Jamitzky F, Heckl WM, et al. (2010) TollML: a database of toll-like receptor structural motifs. J Mol Model 16: 1283-1289.
33. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci Chapter 2: Unit 2 9.
34. Fiser A, Sali A, (2003) ModLoop: automated modeling of loops in protein structures. Bioinformatics 19: 2500-2501.
35. Wang J, Cieplak P, Kollman PA, (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? Journal of Computational Chemistry 21: 1049-1074.
36. Krieger E, Darden T, Nabuurs SB, Finkelstein A, Vriend G, (2004) Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins: Structure, Function, and Bioinformatics 57: 678-683.
37. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM, (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8: 477-486.
38. Eisenberg D, Luthy R, Bowie JU, (1997) VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 277: 396-404.
39. Colovos C, Yeates TO, (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2: 1511-1519.
40. Wiederstein M, Sippl MJ, (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35: W407-410.
41. Tovchigrechko A, Vakser IA, (2006) GRAMM-X public web server for protein-protein docking. Nucleic Acids Res 34: W310-314.
42. Comeau SR, Gatchell DW, Vajda S, Camacho CJ, (2004) ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 32: W96-99.
43. Comeau SR, Gatchell DW, Vajda S, Camacho CJ, (2004) ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 20: 45-50.
44. Bikadi Z, Hazai E, (2009) Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J Cheminform 1: 15.
45. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791.
46. Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, et al. (2005) The FoldX web server: an online force field. Nucleic Acids Res 33: W382-388.
47. Nyman T, Stenmark P, Flodin S, Johansson I, Hammarstrom M, et al. (2008) The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem 283: 11861-11865.
48. Bell JK, Mullen GE, Leifer CA, Mazzoni A, Davies DR, et al. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol 24: 528-533.
49. Gibbard RJ, Morley PJ, Gay NJ, (2006) Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling. J Biol Chem 281: 27503-27511.
50. Matsushima N, Tanaka T, Enkhbayar P, Mikami T, Taga M, et al. (2007) Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 8: 124.
51. Shi J, Blundell TL, Mizuguchi K, (2001) FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 310: 243-257.
52. Govindaraj RG, Manavalan B, Lee G, Choi S, (2010) Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like receptor signaling. PloS one 5: e12713.
53. Basith S, Manavalan B, Govindaraj RG, Choi S, (2011) In silico approach to inhibition of signaling pathways of toll-like receptors 2 and 4 by ST2L. PloS one 6: e23989.
54. Latz E, Verma A, Visintin A, Gong M, Sirois CM, et al. (2007) Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8: 772-779.
55. Wagner TL, Horton VL, Carlson GL, Myhre PE, Gibson SJ, et al. (1997) Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463. Cytokine 9: 837-845.
56. Imbertson LM, Beaurline JM, Couture AM, Gibson SJ, Smith RM, et al. (1998) Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. J Invest Dermatol 110: 734-739.
57. Bernstein DI, Harrison CJ, Tomai MA, Miller RL, (2001) Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. J Infect Dis 183: 844-849.
58. Burns RP Jr, Ferbel B, Tomai M, Miller R, Gaspari AA, (2000) The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells. Clin Immunol 94: 13-23.
59. Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, et al. (2004) Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 34: 2541-2550.
60. Liu J, Xu C, Hsu LC, Luo Y, Xiang R, et al. (2010) A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. Mol Immunol 47: 1083-1090.
61. Wei T, Gong J, Jamitzky F, Heckl WM, Stark RW, et al. (2009) Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains. Protein Sci 18: 1684-1691.
62. Gorden KK, Qiu XX, Binsfeld CC, Vasilakos JP, Alkan SS, (2006) Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. Journal of immunology 177: 6584-6587.
63. Gao ZG, Kim SG, Soltysiak KA, Melman N, AP IJ, et al. (2002) Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives. Molecular pharmacology 62: 81-89.
64. Jurk M, Kritzler A, Schulte B, Tluk S, Schetter C, et al. (2006) Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides. European journal of immunology 36: 1815-1826.
65. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Journal of immunology 168: 4531-4537.
66. Lee J, Chuang TH, Redecke V, She L, Pitha PM, et al. (2003) Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proceedings of the National Academy of Sciences of the United States of America 100: 6646-6651.